

NCT02970773 Raw comparison:

Summary:
CHIA has 18 criteria while your personal folder has 20 criteria
Total found criteria: 18/18
Total not Found: 0/18
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Motor complete tetraplegia for at least 3 months   │ Motor complete tetraplegia for at least 3 months   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Age from 18 to 74 years                            │ Age from 18 to 74 years                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Body mass index (BMI) from 18 to 35kg/m2           │ Body mass index (BMI) from 18 to 35kg/m2           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Informed consent as documented by signature        │ Informed consent as documented by signature        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any anti-coagulation therapy (apart from           │ Any anti-coagulation therapy (apart from           │
│ rivaroxaban for second objective)                  │ rivaroxaban for second objective)                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hypersensitivity or allergy to factor Xa           │ Hypersensitivity or allergy to factor Xa           │
│ inhibitors                                         │ inhibitors                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute bacterial endocarditis                       │ Acute bacterial endocarditis                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Bleeding disorder                                  │ Bleeding disorder                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Clinically relevant active bleeding                │ Clinically relevant active bleeding                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Gastrointestinal ulcer or tumor                    │ Gastrointestinal ulcer or tumor                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatic dysfunction with increased bleeding risk   │ Hepatic dysfunction with increased bleeding risk   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Renal failure / patients undergoing dialysis       │ Renal failure / patients undergoing dialysis       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnancy and breast feeding                       │ Pregnancy and breast feeding                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Gastrectomy biliopancreatic diversion resection or │ Gastrectomy biliopancreatic diversion resection or │
│ re-routing of small intestines                     │ re-routing of small intestines                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Feeding tube                                       │ Feeding tube                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Recent blood donation                              │ Recent blood donation                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Abnormalities of laboratory values alanine-        │ Abnormalities of laboratory values alanine-        │
│ aminotransferase (ALAT) aspartate-aminotransferase │ aminotransferase (ALAT) aspartate-aminotransferase │
│ (ASAT) gamma-glutamyl transferase (gammaGT)        │ (ASAT) gamma-glutamyl transferase (gammaGT)        │
│ alkalic phosphatase (AP) bilirubin amylase lipase  │ alkalic phosphatase (AP) bilirubin amylase lipase  │
│ cystatin C creatinine white blood cell count       │ cystatin C creatinine white blood cell count       │
│ haemoglobin platelet count prothrombin time aPTT   │ haemoglobin platelet count prothrombin time aPTT   │
│ fibrinogen thrombin time factors II V VII and X    │ fibrinogen thrombin time factors II V VII and X    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Use of therapeutic or recreational drugs           │ Use of therapeutic or recreational drugs           │
│ influencing plasmatic coagulation                  │ influencing plasmatic coagulation                  │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must have maximum age of 74 Years │
╘═══════════════════════════════════╛